Tech analysis works sharp at AZN. (not a big tech analysis fan)I'll keep accumulate under the support line. Whenever I sold AZN at resistance, I missed it and placed it back at the next support. Goes well till now.
3.32CHF
5.13 BCHF
39.50 BCHF
1.46 B
About ASTRAZENECA
Sector
CEO
Pascal Soriot
Headquarters
Cambridge
Website
Employees (FY)
89.9 K
Founded
1992
ISIN
GB0009895292
FIGI
BBG007FJNLY7
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Short setupTrying out my first elliot count. Also put a few rising wedges in there. I can't imagine the fundamentals that will bring AZN into such a deep correction though.
AZN AstraZeneca PLC Options Ahead of EarningsAnalyzing the options chain and the chart patterns of AZN AstraZeneca PLC prior to the earnings report this week,
I would consider purchasing the 66usd strike price in the money Puts with
an expiration date of 2023-11-10,
for a premium of approximately $2.30.
If these options prove to be profitable
AZN Starting A Long Journey UpDaily Chart of AZN
AZN bounced from an important support level.
Waves 1 and 2 are complete. Wave 2 ended with a long pin bar. This means that the support level is strong.
Volume has also picked up.
AZN to go up to 75.
Short AgainWe are seeing an upward correction and have reached the MA and the top from 2 days ago again.
The momentum is declining. That's clear - it is a correction.
But as we are in a downtrend since August the preferred direction remains downward.
Resisting HereWe are currently trading within a broader range. However, now we are approaching the important MA which is also the 50% retracement of the decline since August. As the window which had been opened on Monday has been closed now as well I can assume that the test of the high built on September 15th wi
AZN - BEARISH SCENARIOAstraZeneca's stock experienced a significant decline of over 4% on Monday due to uncertainties surrounding the future of CEO Pascal Soriot, as reported in the news. Initially, the company refrained from commenting on the report but later clarified that they do not engage in discussions regarding ma
$AZN with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NASDAQ:AZN after a negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 85.71%.
$AZN with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NASDAQ:AZN after a positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 80%.
$AZN with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for $AZN after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 83.33%.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where AZN is featured.
Frequently Asked Questions
The current price of AZN is 81.00 CHF — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange ASTRAZENECA stocks are traded under the ticker AZN.
ASTRAZENECA is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
AZN stock is 0% volatile and has beta coefficient of 1.17. Check out the list of the most volatile stocks — is ASTRAZENECA there?
One year price forecast for ASTRAZENECA has a max estimate of 192.68 CHF and a min estimate of 114.11 CHF.
AZN earnings for the last quarter are 1.58 CHF per share, whereas the estimation was 1.54 CHF resulting in a 2.59% surprise. The estimated earnings for the next quarter are 1.23 CHF per share. See more details about ASTRAZENECA earnings.
ASTRAZENECA revenue for the last quarter amounts to 10.52 B CHF despite the estimated figure of 10.58 B CHF. In the next quarter revenue is expected to reach 10.17 B CHF.
Yes, you can track ASTRAZENECA financials in yearly and quarterly reports right on TradingView.
AZN net income for the last quarter is 829.36 M CHF, while the quarter before that showed 1.21 B CHF of net income which accounts for −31.59% change. Track more ASTRAZENECA financial stats to get the full picture.
Today ASTRAZENECA has the market capitalization of 192.08 B, it has increased by 0.93% over the last week.
ASTRAZENECA dividend yield was 2.15% in 2023, and payout ratio reached 73.66%. The year before the numbers were 2.13% and 138.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, AZN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTRAZENECA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 89.90 K employees. See our rating of the largest employees — is ASTRAZENECA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASTRAZENECA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASTRAZENECA stock shows the buy signal. See more of ASTRAZENECA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ASTRAZENECA future price: according to them, AZN price has a max estimate of 192.68 CHF and a min estimate of 114.11 CHF. Read a more detailed ASTRAZENECA forecast: see what analysts think of ASTRAZENECA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTRAZENECA EBITDA is 11.06 B CHF, and current EBITDA margin is 31.31%. See more stats in ASTRAZENECA financial statements.